Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Spectrum Pharma Inc (SPPI)

Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spectrum Pharma Inc Pilot House - Lewis Wharf 2 Atlantic Avenue 6th Floor Boston MA 02110 USA

www.sppirx.com P: 617-586-3900

Description:

Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.

Key Statistics

Overview:

Market Capitalization, $K 211,403
Enterprise Value, $K 136,303
Shares Outstanding, K 205,246
Annual Sales, $ 10,110 K
Annual Net Income, $ -75,400 K
Last Quarter Sales, $ 15,620 K
Last Quarter Net Income, $ -5,010 K
60-Month Beta 2.14
% of Insider Shareholders 2.70%
% of Institutional Shareholders 21.67%
Float, K 199,704
% Float 97.30%
Short Volume Ratio 0.23

Growth:

1-Year Return 26.69%
3-Year Return -73.21%
5-Year Return -95.36%
5-Year Revenue Growth -92.12%
5-Year Earnings Growth 59.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 05/09/23
Latest Earnings Date 08/10/23
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr 66.67%
EPS Growth vs. Prev Year 77.78%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.150 on 12/18/12
Dividend Payable Date 12/28/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 09/06/02

SPPI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -218.44%
Return-on-Assets % -66.16%
Profit Margin % -745.80%
Debt/Equity 0.00
Price/Sales 20.90
Price/Cash Flow N/A
Price/Book 7.89
Book Value/Share 0.13
Interest Coverage -77.06

SPPI Dividends

Date Value
12/18/12 $0.1500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar